August 1, 2024
“Headline inflation in the euro zone unexpectedly rose to 2.6% in July, the European Union’s statistics agency said Wednesday. Core inflation, which excludes more volatile energy, food, alcohol and tobacco prices, hit 2.9% in July, which was higher than expected.… Continue Reading…
August 1, 2024
“Shares of global semiconductor firms rallied on Wednesday as they were boosted by some positive earnings in the sector and a report of potentially less severe U.S. export restrictions on China. AMD was among the big winners with shares up… Continue Reading…
August 1, 2024
“Delta CEO Ed Bastian said the massive IT outage earlier this month that stranded thousands of customers will cost it $500 million. The airline canceled more than 5,000 flights in the wake of the outage, which was caused by a… Continue Reading…
August 1, 2024
“…Still, as mistrust in traditional media remains high and readers flock to more identity-focused brands, these projects will likely only gain traction and play an increasingly important role in shaping how the tech industry sees itself and perceives its enemies…”… Continue Reading…
August 1, 2024
“Twelve stocks in the S&P 500, including Walgreens Boots Alliance (WBA), Dexcom (DXCM) and Super Micro Computer (SMCI), have already crashed 40% or more from their 52-week highs, says an Investor’s Business Daily analysis of data from S&P Global Market Intelligence and MarketSurge. A 40% decline is… Continue Reading…
July 31, 2024
“The lower house of Russia’s parliament on Tuesday approved a law that permits making international payments via cryptocurrencies, local media reported. Russia’s central bank is itself looking to move money across borders using crypto before the end of 2024, Governor… Continue Reading…
July 31, 2024
“Well-known entrepreneur and TV personality Kevin O’Leary recently spoke on Fox News about taxing the rich in response to a caller stating, “I just want an America where I have the chance to pay less in taxes than people like Kevin O’Leary.”…”… Continue Reading…
July 31, 2024
“…RegenXBio (RGNX) The first Goldman pick we’ll look at is RegenXBio, a gene therapy company specializing in single-dose treatments for severe diseases with few or no existing therapies…. Choi rates RGNX a Buy along with a $38 price target. This… Continue Reading…
July 31, 2024
“…The private equity firm sold 41.6 million Nasdaq shares for $65.30 each, according to a statement by the exchange operator Monday. A Thoma Bravo affiliate was offering the stock for between $64.80 and $65.80 each, Bloomberg News reported Friday. The… Continue Reading…
Recent Comments